• Galapagos bags option on 4 more Fibrocor programs

    9 days ago - By Fierce Biotech

    Galapagos has struck another deal to expand its fibrosis pipeline, picking up an option to license four Fibrocor programs. The deal comes one year after Galapagos landed global rights to an early-stage idiopathic pulmonary fibrosis treatment in development at Fibrocor.
    Read more ...